Get Premium to unlock powerful stock data
NAS:QURE (Netherlands)  
uniQure NV logo

uniQure NV

$ 19.11 -0.43 (-2.2%) 10:08 PM EST
P/E:
2.77
P/B:
1.63
Market Cap:
$ 891.44M
Enterprise V:
$ 501.96M
Volume:
1.62M
Avg Vol (2M):
690.91K
Also Trade In:
Volume:
1.62M
Market Cap $:
891.44M
PE Ratio:
2.77
Avg Vol (2-Month):
690.91K
Enterprise Value $:
501.96M
PB Ratio:
1.63
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 3.88
Equity-to-Asset 0.72
Debt-to-Equity 0.25
Debt-to-EBITDA 0.4
Interest Coverage 35.67
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.61
Distress
Grey
Safe
Beneish M-Score 9.39
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 81.62
9-Day RSI 74.57
14-Day RSI 68.58
6-1 Month Momentum % -36.18
12-1 Month Momentum % -52.84

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.94
Quick Ratio 12.94
Cash Ratio 11.74
Days Sales Outstanding 15.19
Days Payable 117.97

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.4

Financials (Next Earnings Date:2022-07-26 Est.)

QURE's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:QURE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 525.34
EPS (TTM) ($) 6.89
Beta 1.14
Volatility % 33.86
14-Day RSI 68.58
14-Day ATR ($) 1.243805
20-Day SMA ($) 15.0705
12-1 Month Momentum % -52.84
52-Week Range ($) 12.52 - 38.8
Shares Outstanding (Mil) 46.65

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

uniQure NV Filings

Document Form Filing Date
No Filing Data

Headlines

See More